Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 11-20 of 22 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2015A phase I/II trial of BNC105P with everolimus in metastatic renal cell carcinomaPal, S.; Azad, A.; Bhatia, S.; Drabkin, H.; Costello, B.; Sarantopoulos, J.; Kanesvaran, R.; Lauer, R.; Starodub, A.; Hauke, R.; Sweeney, C.; Hahn, N.; Sonpavde, G.; Richey, S.; Breen, T.; Kremmidiotis, G.; Leske, A.; Doolin, E.; Bibby, D.; Simpson, J.; et al.
2015TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targetsYeung, D.; Osborn, M.; White, D.; Branford, S.; Braley, J.; Herschtal, A.; Kornhauser, M.; Issa, S.; Hiwase, D.; Hertzberg, M.; Schwarer, A.; Filshie, R.; Arthur, C.; Kwan, Y.; Trotman, J.; Forsyth, C.; Taper, J.; Ross, D.; Beresford, J.; Tam, C.; et al.
2011Genome-wide association study identifies susceptibility loci for open angle glaucoma at TMCO1 and CDKN2B-AS1Burdon, K.; MacGregor, S.; Hewitt, A.; Sharma, S.; Chidlow, G.; Mills, R.; Danoy, P.; Casson, R.; Viswanathan, A.; Liu, J.; Landers, J.; Henders, A.; Wood, J.; Souzeau, E.; Crawford, A.; Leo, P.; Wang, J.; Rochtchina, E.; Nyholt, D.; Martin, N.; et al.
2016Health in times of uncertainty in the eastern Mediterranean region, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013Mokdad, A.; Forouzanfar, M.; Daoud, F.; El Bcheraoui, C.; Moradi-Lakeh, M.; Khalil, I.; Afshin, A.; Tuffaha, M.; Charara, R.; Barber, R.; Wagner, J.; Cercy, K.; Kravitz, H.; Coates, M.; Robinson, M.; Estep, K.; Steiner, C.; Jaber, S.; Mokdad, A.; O'Rourke, K.; et al.
2011Bile leakage after hepatobiliary and pancreatic surgery: A definition and grading of severity by the International Study Group of Liver SurgeryKoch, M.; Garden, J.; Padbury, R.; Rahbari, N.; Adam, R.; Capussotti, L.; Sheung, T.; Yokoyama, Y.; Crawford, M.; Makuuchi, M.; Christophi, C.; Banting, S.; Brooke-Smith, M.; Usatoff, V.; Nagino, M.; Maddern, G.; Hugh, T.; Vauthey, J.; Greig, P.; Rees, M.; et al.
2016Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypesMachiela, M.; Lan, Q.; Slager, S.; Vermeulen, R.; Teras, L.; Camp, N.; Cerhan, J.; Spinelli, J.; Wang, S.; Nieters, A.; Vijai, J.; Yeager, M.; Wang, Z.; Ghesquières, H.; McKay, J.; Conde, L.; de Bakker, P.; Cox, D.; Burdett, L.; Monnereau, A.; et al.
2015Analysis of KRAS/NRAS mutations in a phase III study of panitumumab with FOLFIRI compared with FOLFIRI zlone as second-line treatment for metastatic colorectal cancerPeeters, M.; Oliner, K.; Price, T.; Cervantes, A.; Sobrero, A.; Ducreux, M.; Hotko, Y.; André, T.; Chan, E.; Lordick, F.; Punt, C.; Strickland, A.; Wilson, G.; Ciuleanu, T.; Roman, L.; Van Cutsem, E.; He, P.; Yu, H.; Koukakis, R.; Terwey, J.; et al.
2018Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk diseaseBranford, S.; Wang, P.; Yeung, D.T.; Thomson, D.; Purins, A.; Wadham, C.; Shahrin, N.H.; Marum, J.E.; Nataren, N.; Parker, W.T.; Geoghegan, J.; Feng, J.; Shanmuganathan, N.; Mueller, M.C.; Dietz, C.; Stangl, D.; Donaldson, Z.; Altamura, H.; Georgievski, J.; Braley, J.; et al.
2013SMAD2, SMAD3 and SMAD4 mutations in colorectal cancerFleming, N.; Jorissen, R.; Mouradov, D.; Christie, M.; Sakthianandeswaren, A.; Palmieri, M.; Day, F.; Li, S.; Tsui, C.; Lipton, L.; Desai, J.; Jones, I.; McLaughlin, S.; Ward, R.; Hawkins, N.; Ruszkiewicz, A.; Moore, J.; Zhu, H.; Mariadason, J.; Burgess, A.; et al.
2019Secondary and Exploratory Outcomes of the Subthreshold Nanosecond Laser Intervention Randomized Trial in Age-Related Macular Degeneration: A LEAD Study ReportWu, Z.; Luu, C.D.; Hodgson, L.A.B.; Caruso, E.; Brassington, K.H.; Tindill, N.; Aung, K.Z.; Harper, C.A.; Wickremasinghe, S.S.; Sandhu, S.S.; McGuinness, M.B.; Chen, F.K.; Chakravarthy, U.; Arnold, J.J.; Heriot, W.J.; Durkin, S.R.; Wintergerst, M.W.M.; Gorgi Zadeh, S.; Schultz, T.; Finger, R.P.; et al.